Updated FDA Guidance Expands on Development of Antibacterial Drugs for Unmet Needs
July 1, 2022
To encourage development of drugs to treat serious bacterial diseases in patients with an unmet medical need, the FDA has updated a 2017 guidance on antibacterial drug development to indicate the agency may be willing to accept more flexible development programs.